Danielle C Costa, Larissa de O Silveira, Salomão I Queiroz, Wagner R Dantas, José S Da Silva, Adriano R Germano
{"title":"卡诺依溶液治疗侵袭性良性牙源性病变后复发。","authors":"Danielle C Costa, Larissa de O Silveira, Salomão I Queiroz, Wagner R Dantas, José S Da Silva, Adriano R Germano","doi":"10.23736/S0026-4970.19.04230-4","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Chemical curettage has become popular in the definitive treatment of benign aggressive odontogenic lesions. Therefore, this study aims to verify the relapse rate and associated factors after the enucleation protocol, peripheral ostectomy and Carnoy's solution.</p><p><strong>Methods: </strong>This is a retrospective sectional study with 30 patients, selected by non-probabilistic convenience sampling, submitted to the protocol from 2008 to 2018. The study was composed by the data collection phase of the medical records and clinical and radiographic analysis of the patients in order to verify the presence of relapses. Descriptive and statistical analyzes were performed using the Stata/IC version 14.0 program (StataCorp, College Station, TX, USA). The Mann-Whitney Test, Fisher's Exact Test and the χ2 Test, as well as the Kaplan Meier method and the Log-rank Test were used to verify the possible prognostic factors for relapses, adopting P<0.05.</p><p><strong>Results: </strong>The sample consisted of 22 patients with odontogenic keratocysts (73.3%), 3 odontogenic myxomas (10%) and 5 ameloblastomas (16.7%). Relapses affected 7 patients (23.3%), all in odontogenic keratocysts, and the relapse time was between 12-34 months. There was no statistical difference between the evaluated factors and relapse development. Patients who remained with teeth adjacent to the lesion after treatment had an earlier relapse time, a cumulative risk of more than 80% for relapse after 29 months postoperatively, and a 5.5 times greater chance of developing relapses than patients who had their teeth extracted.</p><p><strong>Conclusions: </strong>The protocol is advantageous when compared to isolated treatments and can be used as an alternative to resection.</p>","PeriodicalId":18742,"journal":{"name":"Minerva stomatologica","volume":"68 5","pages":"242-248"},"PeriodicalIF":0.0000,"publicationDate":"2019-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Relapses after using Carnoy's solution in treating aggressive benign odontogenic lesions.\",\"authors\":\"Danielle C Costa, Larissa de O Silveira, Salomão I Queiroz, Wagner R Dantas, José S Da Silva, Adriano R Germano\",\"doi\":\"10.23736/S0026-4970.19.04230-4\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Chemical curettage has become popular in the definitive treatment of benign aggressive odontogenic lesions. Therefore, this study aims to verify the relapse rate and associated factors after the enucleation protocol, peripheral ostectomy and Carnoy's solution.</p><p><strong>Methods: </strong>This is a retrospective sectional study with 30 patients, selected by non-probabilistic convenience sampling, submitted to the protocol from 2008 to 2018. The study was composed by the data collection phase of the medical records and clinical and radiographic analysis of the patients in order to verify the presence of relapses. Descriptive and statistical analyzes were performed using the Stata/IC version 14.0 program (StataCorp, College Station, TX, USA). The Mann-Whitney Test, Fisher's Exact Test and the χ2 Test, as well as the Kaplan Meier method and the Log-rank Test were used to verify the possible prognostic factors for relapses, adopting P<0.05.</p><p><strong>Results: </strong>The sample consisted of 22 patients with odontogenic keratocysts (73.3%), 3 odontogenic myxomas (10%) and 5 ameloblastomas (16.7%). Relapses affected 7 patients (23.3%), all in odontogenic keratocysts, and the relapse time was between 12-34 months. There was no statistical difference between the evaluated factors and relapse development. Patients who remained with teeth adjacent to the lesion after treatment had an earlier relapse time, a cumulative risk of more than 80% for relapse after 29 months postoperatively, and a 5.5 times greater chance of developing relapses than patients who had their teeth extracted.</p><p><strong>Conclusions: </strong>The protocol is advantageous when compared to isolated treatments and can be used as an alternative to resection.</p>\",\"PeriodicalId\":18742,\"journal\":{\"name\":\"Minerva stomatologica\",\"volume\":\"68 5\",\"pages\":\"242-248\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Minerva stomatologica\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.23736/S0026-4970.19.04230-4\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Minerva stomatologica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23736/S0026-4970.19.04230-4","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 1
摘要
背景:化学刮除术已成为良性侵袭性牙源性病变的最终治疗方法。因此,本研究旨在验证去核方案、周围骨切除术和Carnoy溶液后的复发率及其相关因素。方法:本研究是一项回顾性断面研究,采用非概率方便抽样方法选择2008年至2018年提交方案的30例患者。本研究由病历资料收集阶段和患者的临床和放射学分析组成,以验证复发的存在。使用Stata/IC 14.0版本程序(StataCorp, College Station, TX, USA)进行描述性和统计分析。采用Mann-Whitney检验、Fisher’s Exact检验、χ2检验、Kaplan Meier法和Log-rank检验对复发的可能预后因素进行验证,结果:本组牙源性角化囊肿22例(73.3%),牙源性黏液瘤3例(10%),成釉细胞瘤5例(16.7%)。复发7例(23.3%),均为牙源性角化囊肿,复发时间12 ~ 34个月。评估因素与复发发展之间无统计学差异。治疗后牙齿与病变相邻的患者复发时间较早,术后29个月复发的累积风险超过80%,复发的几率是拔牙患者的5.5倍。结论:与孤立治疗相比,该方案是有利的,可以作为切除的替代方法。
Relapses after using Carnoy's solution in treating aggressive benign odontogenic lesions.
Background: Chemical curettage has become popular in the definitive treatment of benign aggressive odontogenic lesions. Therefore, this study aims to verify the relapse rate and associated factors after the enucleation protocol, peripheral ostectomy and Carnoy's solution.
Methods: This is a retrospective sectional study with 30 patients, selected by non-probabilistic convenience sampling, submitted to the protocol from 2008 to 2018. The study was composed by the data collection phase of the medical records and clinical and radiographic analysis of the patients in order to verify the presence of relapses. Descriptive and statistical analyzes were performed using the Stata/IC version 14.0 program (StataCorp, College Station, TX, USA). The Mann-Whitney Test, Fisher's Exact Test and the χ2 Test, as well as the Kaplan Meier method and the Log-rank Test were used to verify the possible prognostic factors for relapses, adopting P<0.05.
Results: The sample consisted of 22 patients with odontogenic keratocysts (73.3%), 3 odontogenic myxomas (10%) and 5 ameloblastomas (16.7%). Relapses affected 7 patients (23.3%), all in odontogenic keratocysts, and the relapse time was between 12-34 months. There was no statistical difference between the evaluated factors and relapse development. Patients who remained with teeth adjacent to the lesion after treatment had an earlier relapse time, a cumulative risk of more than 80% for relapse after 29 months postoperatively, and a 5.5 times greater chance of developing relapses than patients who had their teeth extracted.
Conclusions: The protocol is advantageous when compared to isolated treatments and can be used as an alternative to resection.
期刊介绍:
The journal Minerva Stomatologica publishes scientific papers on dentistry and maxillo-facial surgery. Manuscripts may be submitted in the form of editorials, original articles, review articles, case reports, therapeutical notes, special articles and letters to the Editor. Manuscripts are expected to comply with the instructions to authors which conform to the Uniform Requirements for Manuscripts Submitted to Biomedical Editors by the International Committee of Medical Journal Editors (www.icmje.org). Articles not conforming to international standards will not be considered for acceptance.